Current Perspectives on Maternal Influenza Immunization
- 20 Downloads
Purpose of Review
Pregnant women and young infants are more likely to experience severe complications associated with influenza infection and are at increased risk of hospitalization. Influenza vaccination during pregnancy produces antibodies which protect the mother against infection, and due to transplacental transfer of maternal antibodies before birth, it also protects the infant in the first few months of life.
In many countries, influenza vaccination is recommended during pregnancy to protect mothers and their infants. In fact, influenza vaccine is the most widely used vaccine in pregnancy globally. When administered during pregnancy, the vaccine has been shown to be safe and effective for both mothers and their infants. Despite the health benefits, acceptance of influenza vaccine is low during pregnancy, indicating many women and infants are not protected against influenza.
Concerted efforts are needed globally to improve the proportion of women and young infants who receive the health benefits of influenza vaccination.
KeywordsInfluenza vaccines Influenza Maternal vaccination Pregnant women Infant health
This work was partly funded by the Norwegian Research council’s Centre’s of Excellence funding scheme (#262700).
Compliance With Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.CDC. Flu symptoms and complications. 2019. https://www.cdc.gov/flu/symptoms/symptoms.htm. Accessed August 14 2019.
- 7.Littauer EQ, Esser ES, Antao OQ, Vassilieva EV, Compans RW, Skountzou I. H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation. PLoS Pathog. 2017;13(11):e1006757. https://doi.org/10.1371/journal.ppat.1006757.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176(4):463–8. https://doi.org/10.1503/cmaj.061435.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Fell DB, Platt RW, Basso O, Wilson K, Kaufman JS, Buckeridge DL, et al. The relationship between 2009 pandemic H1N1 influenza during pregnancy and preterm birth: a population-based cohort study. Epidemiology. 2018;29(1):107–16. https://doi.org/10.1097/ede.0000000000000753.CrossRefPubMedGoogle Scholar
- 17.Hansen C, Desai S, Bredfeldt C, Cheetham C, Gallagher M, Li DK, et al. A large, population-based study of 2009 pandemic influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis. 2012;206(8):1260–8. https://doi.org/10.1093/infdis/jis488.CrossRefPubMedGoogle Scholar
- 18.•• Katz J, Englund JA, Steinhoff MC, Khatry SK, Shrestha L, Kuypers J, et al. Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence, and birth outcomes: a randomized trial in rural Nepal. Clin Infect Dis. 2018;67(3):334–40. https://doi.org/10.1093/cid/ciy090Authors report evidence from clinical trial evaluating cord blood antibody titers by gestational age at influenza vaccine administration. Findings show that vaccine efficacy did not vary by gestational age at vaccination, which has implications for immunization policy and practice.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Blyth CC, Macartney KK, Hewagama S, Senenayake S, Friedman ND, Simpson G, et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Euro Surveill. 2016;21(30). https://doi.org/10.2807/1560-7917.es.2016.21.30.30301.
- 28.• Omer SB. Maternal immunization. New Engl J Med. 2017;376(13):1256–67. https://doi.org/10.1056/NEJMra1509044Review article which provides a summary of the results of three recent clinical trials evaluating prenatal influenza vaccine efficacy against maternal and infant infection.CrossRefPubMedGoogle Scholar
- 30.Tapia MD, Sow SO, Tamboura B, Teguete I, Pasetti MF, Kodio M, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis. 2016;16(9):1026–35. https://doi.org/10.1016/s1473-3099(16)30054-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.• Steinhoff MC, Katz J, Englund JA, Khatry SK, Shrestha L, Kuypers J, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis. 2017;17(9):981–9. https://doi.org/10.1016/s1473-3099(17)30252-9Results from this clinical trial suggest that influenza vaccination of pregnant women throughout the year would offer significant protection to pregnant women and their infants in subtropical regions, where influenza circulates year-round.CrossRefPubMedPubMedCentralGoogle Scholar
- 40.CDC. Recommendations for influenza immunization and control in the civilian population - 1965-66. MMWR Morb Mortal Wkly Rep. 1965;14(24):203–8.Google Scholar
- 41.CDC. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1995;44(Rr-3):1–22.Google Scholar
- 42.CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2004;53(Rr-6):1–40.Google Scholar
- 44.RANZCOG. Influenza vaccination during pregnancy (and women planning pregnancy) C-Obs 45. 2017. https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27 s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Influenza-vaccination-in-pregnancy-(C-Obs-45)-Review-March-2017.pdf?ext = .pdf. Accessed 6 September 2019.
- 46.PHAC. An Advisory Committee Statement (ACS) NAtional Advisory Committee on Immunization (NACI): canadian immunization guide chapter on influenza and statement of seaosnal influenza vaccine for 2019-20. 2019. https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/canadian-immunization-guide-statement-seasonal-influenza-vaccine-2019-2020.html. Accessed 6 September 2019.
- 47.ECDC. Seasonal influenza vaccination in Europe: vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007-2008 to 2014-15. Stockholm: ECDC; 2017.Google Scholar
- 48.CDC. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists--United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep. 2005;54(41):1050–2.Google Scholar
- 51.WHO. Swine flu illness in the United States and Mexico - update 2. https://www.who.int/csr/don/2009_04_26/en/. Accessed August 12 2019.
- 52.WHO. Influenza A(H1N1) - update 41. https://www.who.int/csr/don/2009_05_29/en/. Accessed August 12 2019.
- 53.WHO. Pandemic (H1N1) 2009 - update 61. https://www.who.int/csr/don/2009_08_12/en/. Accessed August 12 2019.
- 55.CDC. Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. MMWR Morb Mortal Wkly Rep. 2009;58(18):497–500.Google Scholar
- 56.CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58(19):521–4.Google Scholar
- 57.CDC. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women--10 states, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep. 2010;59(47):1541–5.Google Scholar
- 59.McCarthy EA, Pollock WE, Tapper L, Sommerville M, McDonald S. Increasing uptake of influenza vaccine by pregnant women post H1N1 pandemic: a longitudinal study in Melbourne, Australia, 2010 to 2014. BMC Pregnancy Childbirth. 2015;15:53–7. https://doi.org/10.1186/s12884-015-0486-3.CrossRefPubMedPubMedCentralGoogle Scholar
- 63.WHO. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rev. 2012;87(47):461–76.Google Scholar
- 64.Ortiz JR, Perut M, Dumolard L, Wijesinghe PR, Jorgensen P, Ropero AM, et al. A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine. 2016;34(45):5400–5. https://doi.org/10.1016/j.vaccine.2016.07.045.CrossRefPubMedPubMedCentralGoogle Scholar
- 66.Simoes EAF, Nunes MC, Carosone-Link P, Madimabe R, Ortiz JR, Neuzil KM, et al. Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes. Vaccine. 2019;37(36):5397–403. https://doi.org/10.1016/j.vaccine.2019.07.024.CrossRefPubMedPubMedCentralGoogle Scholar
- 69.McHugh L, Andrews RM, Lambert SB, Viney KA, Wood N, Perrett KP, et al. Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: the FluMum study. Vaccine. 2017;35(10):1403–9. https://doi.org/10.1016/j.vaccine.2017.01.075.CrossRefPubMedGoogle Scholar
- 70.McHugh L, Marshall HS, Perrett KP, Nolan T, Wood N, Lambert SB, et al. The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the FluMum Study. Clin Infect Dis. 2019;68(3):402–8. https://doi.org/10.1093/cid/ciy517.CrossRefPubMedGoogle Scholar
- 71.Regan AK, Moore HC, de Klerk N, Omer SB, Shellam G, Mak DB, et al. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin Infect Dis. 2016;62(10):1221–7. https://doi.org/10.1093/cid/ciw082.CrossRefPubMedGoogle Scholar
- 75.Baum U, Leino T, Gissler M, Kilpi T, Jokinen J. Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: a cohort study of pregnancies stratified by trimester of vaccination. Vaccine. 2015;33(38):4850–7. https://doi.org/10.1016/j.vaccine.2015.07.061.CrossRefPubMedGoogle Scholar
- 76.Chavant F, Ingrand I, Jonville-Bera AP, Plazanet C, Gras-Champel V, Lagarce L, et al. The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. Drug Saf. 2013;36(6):455–65. https://doi.org/10.1007/s40264-013-0030-1.CrossRefPubMedGoogle Scholar
- 79.Louik C, Kerr S, Van Bennekom CM, Chambers C, Jones KL, Schatz M, et al. Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: preterm delivery and specific malformations, a study from the case-control arm of VAMPSS. Vaccine. 2016;34(37):4450–9. https://doi.org/10.1016/j.vaccine.2016.06.078.CrossRefPubMedGoogle Scholar
- 80.Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, et al. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine. 2014;32(26):3122–7. https://doi.org/10.1016/j.vaccine.2014.04.021.CrossRefPubMedPubMedCentralGoogle Scholar
- 81.Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30(30):4445–52. https://doi.org/10.1016/j.vaccine.2012.04.081.CrossRefPubMedGoogle Scholar
- 82.Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine. 2011;29(37):6358–65. https://doi.org/10.1016/j.vaccine.2011.04.114.CrossRefPubMedGoogle Scholar
- 83.Omon E, Damase-Michel C, Hurault-Delarue C, Lacroix I, Montastruc JL, Oustric S, et al. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine. 2011;29(52):9649–54. https://doi.org/10.1016/j.vaccine.2011.10.034.CrossRefPubMedGoogle Scholar
- 84.Chambers CD, Johnson D, Xu R, Luo Y, Louik C, Mitchell AA, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013;31(44):5026–32. https://doi.org/10.1016/j.vaccine.2013.08.097.CrossRefPubMedGoogle Scholar
- 85.Chambers CD, Johnson DL, Xu R, Luo YJ, Louik C, Mitchell AA, et al. Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine. 2016;34(37):4443–9. https://doi.org/10.1016/j.vaccine.2016.06.054.CrossRefPubMedGoogle Scholar
- 88.Regan AK, Tracey L, Blyth CC, Mak DB, Richmond PC, Shellam G, et al. A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women. BMC Pregnancy Childbirth. 2015;15:61–7. https://doi.org/10.1186/s12884-015-0495-2.CrossRefPubMedPubMedCentralGoogle Scholar
- 89.• Regan AK, Tracey LE, Blyth CC, Richmond PC, Effler PV. A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy. Vaccine. 2016;34(20):2299–304. https://doi.org/10.1016/j.vaccine.2016.03.084Results from this prospective cohort study identified no increase in adverse events following influenza vaccine, given on its own or in combination with pertussis vaccine.CrossRefPubMedGoogle Scholar
- 92.Moro P, Baumblatt J, Lewis P, Cragan J, Tepper N, Cano M. Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016. Drug Saf. 2017;40(2):145–52. https://doi.org/10.1007/s40264-016-0482-1.CrossRefPubMedPubMedCentralGoogle Scholar
- 93.Haber P, Moro PL, Cano M, Lewis P, Stewart B, Shimabukuro TT. Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014. Vaccine. 2015;33(16):1987–92. https://doi.org/10.1016/j.vaccine.2015.01.080.CrossRefPubMedGoogle Scholar
- 96.McMillan M, Porritt K, Kralik D, Costi L, Marshall H. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015;33(18):2108–17. https://doi.org/10.1016/j.vaccine.2015.02.068.CrossRefPubMedGoogle Scholar
- 102.• Walsh LK, Donelle J, Dodds L, Hawken S, Wilson K, Benchimol EI, et al. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ. 2019;366:l4151. https://doi.org/10.1136/bmj.l4151First cohort study to evaluate the risk of a range of pre-specified pediatric health outcomes associated with 2009 monovalent pandemic A/H1N1 vaccination during pregnancy.CrossRefPubMedPubMedCentralGoogle Scholar
- 103.•• Cuningham W, Geard N, Fielding JE, Braat S, Madhi SA, Nunes MC, et al. Optimal timing of influenza vaccine during pregnancy: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2019;13(5):438–52. https://doi.org/10.1111/irv.12649Recent systematic review which highlights differences in the immunogenicity of influenza vaccine administered at different stages of pregnancy as observed in matenral sera and cord blood.CrossRefPubMedPubMedCentralGoogle Scholar
- 104.Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, et al. First trimester influenza vaccination and risks for major structural birth defects in offspring. J Pediatr. 2017;187:234–9.e4. https://doi.org/10.1016/j.jpeds.2017.04.039.CrossRefPubMedPubMedCentralGoogle Scholar
- 110.Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, et al. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. Vaccine. 2017;35(40):5314–22. https://doi.org/10.1016/j.vaccine.2017.06.069.CrossRefPubMedPubMedCentralGoogle Scholar
- 111.CDC. Flu vaccination & addressing concerns pregnatn women might have about flu vaccine safety. https://www.cdc.gov/flu/professionals/vaccination/vaccination-possible-safety-signal.html. Accessed 6 September 2019.
- 113.Dabrera G, Zhao H, Andrews N, Begum F, Green H, Ellis J, et al. Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14. Euro Surveill. 2014;19(45):20959. https://doi.org/10.2807/1560-7917.es2014.19.45.20959.CrossRefPubMedGoogle Scholar
- 115.Thompson MG, Li DK, Shifflett P, Sokolow LZ, Ferber JR, Kurosky S, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis. 2014;58(4):449–57. https://doi.org/10.1093/cid/cit750.CrossRefPubMedGoogle Scholar
- 116.Thompson MG, Kwong JC, Regan AK, Katz MA, Drews SJ, Azziz-Baumgartner E, et al. Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016. Clin Infect Dis. 2019;68(9):1444–53. https://doi.org/10.1093/cid/ciy737.CrossRefPubMedGoogle Scholar
- 117.Regan AK, Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: a retrospective cohort study. Vaccine. 2016;34(32):3649–56. https://doi.org/10.1016/j.vaccine.2016.05.032.CrossRefPubMedGoogle Scholar
- 118.Regan AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: a retrospective cohort study. Pediatr Infect Dis J. 2016;35(10):1097–103. https://doi.org/10.1097/inf.0000000000001258.CrossRefPubMedGoogle Scholar
- 120.Nunes MC, Cutland CL, Jones S, Downs S, Weinberg A, Ortiz JR, et al. Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial. Clin Infect Dis. 2017;65(7):1066–71. https://doi.org/10.1093/cid/cix497.CrossRefPubMedPubMedCentralGoogle Scholar
- 121.France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med. 2006;160(12):1277–83. https://doi.org/10.1001/archpedi.160.12.1277.CrossRefPubMedGoogle Scholar
- 122.Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21(6):333–9. https://doi.org/10.1055/s-2004-831888.CrossRefPubMedGoogle Scholar
- 125.Office of Disease Prevention and Health Promotion. IID-12.10 Increase the percentage of pregnant women who are vaccinated against seasonal influenza. https://www.healthypeople.gov/node/4660/data_details. Accessed 31 July 2019.
- 132.Palmer S, Pudwell J, Smith GN, Reid RL. Optimizing participation of pregnant women in clinical trials: factors influencing decisions about participation in medication and vaccine trials. J Obstet Gynaecol Can. 2016;38(10):945–54. https://doi.org/10.1016/j.jogc.2016.04.100.CrossRefPubMedGoogle Scholar
- 133.Cutland CL, Cunnington M, Olugbosi M, Jones SA, Hugo A, Maharaj K, et al. Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country. Vaccine. 2015;33(47):6406–12. https://doi.org/10.1016/j.vaccine.2015.08.040.CrossRefPubMedGoogle Scholar
- 134.Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, et al. Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: a multicenter questionnaire study. Pediatr Infect Dis J. 2019;38(9):944–51. https://doi.org/10.1097/inf.0000000000002384.CrossRefPubMedGoogle Scholar
- 135.Top KA, Arkell C, Scott H, McNeil SA, Mannerfeldt J, Ortiz JR, et al. Effect of package insert language on health-care providers’ perceptions of influenza vaccination safety during pregnancy. Lancet Global Health. 2016;4(10):e690–1. https://doi.org/10.1016/s2214-109x(16)30182-6.CrossRefPubMedGoogle Scholar
- 137.Krubiner CB, Faden RR, Karron RA, Little MO, Lyerly AD, Abramson JS, et al. Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response. Vaccine. 2019; in press. https://doi.org/10.1016/j.vaccine.2019.01.011.
- 138.McQuaid F, Jones C, Stevens Z, Meddaugh G, O’Sullivan C, Donaldson B, et al. Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. Acta Obstet Gynecol Scand. 2018;97(3):330–40. https://doi.org/10.1111/aogs.13288.CrossRefPubMedGoogle Scholar
- 140.Schwartz DA. Clinical trials and administration of Zika virus vaccine in pregnant women: lessons (that should have been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation. Vaccines (Basel). 2018;6(4):E81. https://doi.org/10.3390/vaccines6040081.CrossRefGoogle Scholar
- 143.Stockwell MS, Westhoff C, Kharbanda EO, Vargas CY, Camargo S, Vawdrey DK, et al. Influenza vaccine text message reminders for urban, low-income pregnant women: a randomized controlled trial. Am J Public Health. 2014;104(Suppl 1):e7–12. https://doi.org/10.2105/ajph.2013.301620.CrossRefPubMedPubMedCentralGoogle Scholar
- 146.Kochhar S, Edwards KM, Ropero Alvarez AM, Moro PL, Ortiz JR. Introduction of new vaccines for immunization in pregnancy - programmatic, regulatory, safety and ethical considerations. Vaccine. 2019;37(25):3267–77. https://doi.org/10.1016/j.vaccine.2019.04.075.CrossRefPubMedPubMedCentralGoogle Scholar
- 147.Sobanjo-Ter Meulen A, Munoz FM, Kaslow DC, Klugman KP, Omer SB, Vora P, et al. Maternal interventions vigilance harmonization in low- and middle-income countries: stakeholder meeting report; Amsterdam, May 1-2, 2018. Vaccine. 2019;37(20):2643–50. https://doi.org/10.1016/j.vaccine.2019.03.060.CrossRefPubMedPubMedCentralGoogle Scholar
- 148.Kochhar S, Clarke E, Izu A, Emmanuel Kekane-Mochwari K, Cutland CL. Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions. Vaccine. 2019;37(22):2967–74. https://doi.org/10.1016/j.vaccine.2019.03.074.CrossRefPubMedGoogle Scholar
- 150.Sobanjo-Ter Meulen A, Abramson J, Mason E, Rees H, Schwalbe N, Bergquist S, et al. Path to impact: a report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015. Vaccine. 2015;33(47):6388–95. https://doi.org/10.1016/j.vaccine.2015.08.047.CrossRefPubMedGoogle Scholar